| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |